Breast and ovarian cancer || Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)






Last Updated: Aug 30, 2016

• High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
  Rashid Muhammad Usman, et al. BMC cancer 2016 0 (1) 673
• Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
  Pinto Pedro, et al. Breast cancer research and treatment 2016 8
• Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
  Pokharel Hanoon P et al. The Australian & New Zealand journal of obstetrics & gynaecology 2016 Aug
• Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.
  Pasick Rena J et al. American journal of public health 2016 Aug e1-e7
• Hereditary breast and ovarian cancer: new genes in confined pathways.
  Nielsen Finn Cilius, et al. Nature reviews. Cancer 2016 8
• Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
  Kiechle Marion et al. Trials 2016 17368
• Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?
  Cragun Deborah et al. Genetic testing and molecular biomarkers 2016 Aug
• Finding all BRCA pathogenic mutation carriers: best practice models.
  Hoogerbrugge Nicoline et al. European journal of human genetics : EJHG 2016 Sep 24 Suppl 1S19-26
• How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
  Watts Kaaren J et al. BMC cancer 2012 12320
• Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
  Joseph Galen et al. Journal of genetic counseling 2010 Oct 19(5) 447-62
• Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
  Modell Stephen M et al. Translational research : the journal of laboratory and clinical medicine 2014 May 163(5) 466-77
• The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
  Trivers Katrina F et al. Healthcare (Basel, Switzerland) 2015 3(4) 948-63
• Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
  Giordano Sara, et al. Journal of adolescent and young adult oncology 2016 8
• Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.
  Rump Andreas, et al. PLoS genetics 2016 8 (8) e1006248
• Community attitudes towards a Jewish community BRCA1/2 testing program.
  Cousens Nicole et al. Familial cancer 2016 Aug

• CDC Information (7)
• CDC-Authored Pub (2)

• Human (25)
• Pathogen (0)

• Human (694)
• Pathogen (0)

• Human (156)
• Pathogen (0)

• Guidelines (8)
• Tier Table (3)
• Synthesis (8)

• Huamn (83)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB